4//SEC Filing
Cardiovascular Systems Inc 4
Accession 0000914190-16-000880
CIK 0001180145operating
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:39 PM ET
Size
11.0 KB
Accession
0000914190-16-000880
Insider Transaction Report
Form 4
Brown Edward M
Director
Transactions
- Sale
Common Stock
2016-11-17$26.59/sh−700$18,616→ 133,337 total(indirect: By Trust) - Sale
Common Stock
2016-11-18$26.79/sh−9,300$249,180→ 124,037 total(indirect: By Trust)
Holdings
- 5,949
Restricted Stock Units
→ Common Stock (5,949 underlying) - 69,587
Restricted Stock Units
→ Common Stock (69,587 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $26.66 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.02 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
- [F4]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,488 shares on September 30, 2016 and 1,487 shares on each of December 31, 2016, March 31, 2017 and June 30, 2017.
- [F5]Represents the aggregate number of restricted stock units (all previously reported) held by reporting person that are payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
Documents
Issuer
Cardiovascular Systems Inc
CIK 0001180145
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001180145
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 4:39 PM ET
- Size
- 11.0 KB